Tag: gastrointestinal pathogen testing market share

Uncover key drivers, emerging technologies, and competitive movements shaping the gastrointestinal pathogen testing market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Gastrointestinal Pathogen Testing Market in 2026, and what figure is it projected to hit by 2030?

The gastrointestinal pathogen testing market size has shown consistent growth in recent years. This market is expected to increase from $4.23 billion in 2025 to $4.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. Historically, this expansion has been influenced by the high incidence of gastrointestinal infections, the widespread adoption of culture-based testing, the enlargement of hospital laboratories, occurrences of foodborne illness outbreaks, and the establishment of public health surveillance programs.

The gastrointestinal pathogen testing market size is anticipated to show stable development over the coming period. This market is set to reach $5.06 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. The expansion during this forecast timeframe is primarily driven by an increase in syndromic testing panels, the broadening of point-of-care diagnostics, the need for faster turnaround times, the incorporation of molecular diagnostics, and heightened awareness of infectious diseases. Prominent trends within the forecast period encompass the increasing application of multiplex molecular diagnostic panels, a greater need for rapid stool testing, the broadening of point-of-care GI diagnostics, the increasing acceptance of PCR-based testing, and a stronger emphasis on infection surveillance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

Which Drivers Are Affecting Market Participation In The Gastrointestinal Pathogen Testing Market?

The increasing occurrence of foodborne illnesses is projected to stimulate growth within the gastrointestinal pathogen testing market. These illnesses arise from consuming food or drinks contaminated with harmful microorganisms, toxins, or chemicals, encompassing conditions like listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The escalation in foodborne incidents stems from various factors, including evolving patterns in food production, distribution, and consumption, insufficient food safety protocols, and the impact of climate change on food supply. Gastrointestinal testing plays a crucial role by identifying specific pathogens responsible for these illnesses, enabling healthcare providers to pinpoint the cause of symptoms, prescribe suitable treatment, track outbreaks, and implement preventative measures to curb the spread of foodborne diseases. For example, in September 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that during 2023, the CDC, in collaboration with state and regulatory public health partners, investigated 181 potential multistate outbreaks, with 84 confirmed as actual outbreaks. Outbreak investigators resolved 50 of these outbreaks (60%), identifying a suspected source for 22 and a confirmed source for 28. Consequently, the rising instances of foodborne diseases are propelling the expansion of the gastrointestinal pathogen testing market. The growing challenge of antimicrobial resistance is anticipated to propel the expansion of the gastrointestinal pathogen testing market. Antimicrobial resistance describes the capability of microorganisms such as bacteria and viruses to resist the effects of medications previously effective against them. The demand for gastrointestinal pathogen testing is escalating due to the increasing prevalence of drug-resistant gastrointestinal infections, which necessitate prompt and accurate detection to guide effective treatment and prevent further dissemination. For instance, in October 2025, the World Health Organization, a Switzerland-based specialized agency of the United Nations, stated that it provided a global analysis of antibiotic resistance prevalence and trends, utilizing data from over 23 million bacteriologically confirmed cases of bloodstream infections, urinary tract infections, gastrointestinal infections, and urogenital gonorrhea. Data for this analysis were submitted by 104 countries in 2023. Thus, the escalating antimicrobial resistance is expected to stimulate the gastrointestinal pathogen testing market.

What Segment Classifications Make Up The Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites

2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types

4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:

1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens

2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens

3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

What Trends Are Driving The Growth Trajectory Of The Gastrointestinal Pathogen Testing Market?

Major companies operating in the gastrointestinal pathogen testing market are concentrating on developing advanced solutions, such as metagenomic diagnostic tests, to enhance the accuracy, speed, and comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test represents an advanced technology utilized to analyze the genetic material of microorganisms present in a sample, such as stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test engineered to identify a wide array of gastrointestinal pathogens with unparalleled accuracy. MetaPanel encompasses 175 pathogen targets in a single test, providing healthcare professionals a comprehensive tool for diagnosing both common and hard-to-detect infections. It employs next-generation sequencing (NGS) technology to examine a broad range of genetic material within a stool sample. This enables the detection of a diverse variety of potential pathogens, including those not routinely tested for in traditional GI (gastrointestinal) panels.

Which Leading Companies Dominate The Gastrointestinal Pathogen Testing Market Share?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gastrointestinal Pathogen Testing Market?

North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastrointestinal Pathogen Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2026, By The Business Research Company

Food Pathogen Safety Testing Equipment And Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

Food Pathogen Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

Infectious Disease Diagnostics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Gastrointestinal Pathogen Testing Market?

The market size for testing gastrointestinal pathogens has seen consistent growth over the past few years. The market size is projected to increase from $4.05 billion in 2024 to $4.23 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the rising occurrence of gastrointestinal infections, increasing awareness regarding illnesses caused by contaminated food, the impact of globalization increasing the incidence of infections related to travel, various food safety regulations, an increase in healthcare spending, and the amplified demand for quick and precise diagnostic solutions.

In the coming years, the market for gastrointestinal pathogen testing is predicted to witness consistent expansion, reaching around $4.92 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 3.9%. This surge in the prediction period can be associated with the global increase in gastrointestinal infections, heightened knowledge regarding the necessity of early diagnosis and treatment, development of healthcare facilities in evolving economies, growing need for point-of-care testing alternatives, increased emphasis on food safety protocols, and constant research and development initiatives. The forecast period witnesses major trends including swift testing approaches, the rising prevalence of molecular diagnostic techniques, enlargement of point-of-care testing in unconventional healthcare environments, advancements in automation and robotics for effective testing procedures, the discovery of innovative biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine learning mechanisms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What Core Drivers Are Expected To Influence The Gastrointestinal Pathogen Testing Market?

The surge in foodborne disease occurrences is poised to drive the expansion of the gastrointestinal pathogen testing market in the future. These diseases, which are the result of consuming food or drinks contaminated with harmful microorganisms, toxins, or chemicals, encompass conditions such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The uptick in these incidents can be attributed to several factors, including modifications in food production, distribution, and consumption habits, substandard food safety precautions, and the effects of climatic changes on food production. Gastrointestinal pathogen screening aids in pinpointing the exact perpetrators of these foodborne ailments, thus enabling healthcare practitioners to identify the root of gastrointestinal symptoms, prescribe appropriate treatments, trace contagions, and introduce preventative strategies to limit the proliferation of foodborne diseases. For example, England and Wales recorded 167 cases of listeriosis in 2022, compared to 160 cases in 2021, according to the UK Health Security Agency, a British governmental entity, in February 2024. Consequently, the escalating occurrences of foodborne diseases are fuelling the development of the gastrointestinal pathogen testing market.

What Are The Main Segment Classifications In The Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testingmarket covered in this report is segmented –

1) By Pathogen Type: Bacteria; Viruses; Parasites

2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types

4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users

Subsegments:

1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens

2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens

3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens

How Are Industry Trends Steering The Expansion Of The Gastrointestinal Pathogen Testing Market?

Leading corporations in the gastrointestinal pathogen testing domain are prioritizing the creation of cutting-edge remedies, like metagenomic diagnostic tests, to bolster the precision, rapidity, and all-inclusive detection of gastrointestinal pathogens. Metagenomic diagnostic tests represent a sophisticated technology for scrutinizing the genetic constituents of microorganisms within a given specimen, such as blood or stool. Micorba Life Sciences, an Australian biotechnology enterprise, for example, unveiled MetaPanel in April 2024, a metagenomic diagnostic test engineered to pinpoint an extensive array of gastrointestinal pathogens with unmatched accuracy. MetaPanel is competent in encompassing 175 pathogen targets within a single test, thereby providing medical specialists with a thorough solution for diagnosing both prevalent and elusive infections. By leveraging next-generation sequencing (NGS) technology, it inspects a wide spectrum of genetic material in a stool specimen, facilitating the detection of an extensive array of potential pathogens, including those not customarily tested in traditional gastrointestinal panels.

Which Companies Are Contributing Significantly To The Gastrointestinal Pathogen Testing Market Growth?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Region Holds The Greatest Opportunity For Gastrointestinal Pathogen Testing Market Expansion?

North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2025, By The Business Research Company

Gastrointestinal Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Food Pathogen Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Gastrointestinal Pathogen Testing Market From 2025 To 2034?

The gastrointestinal pathogen testing market size has consistently expanded in recent years. This market is set to increase from $4.05 billion in 2024 to $4.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.4%. The historical growth of this market can be attributed to several factors, including the rising occurrence of gastrointestinal infections, enhanced awareness regarding foodborne illnesses, globalization leading to an uptick in travel-related infections, regulatory measures for food safety, an increase in healthcare spending, and a greater demand for swift and precise diagnostic solutions.

The market size for gastrointestinal pathogen testing is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $4.92 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.9%. The observed growth during this forecast timeframe stems from several factors, including the global rise in gastrointestinal infections, greater understanding of the necessity for prompt diagnosis and intervention, the development of healthcare infrastructure in developing nations, an increasing need for point-of-care testing methods, strengthened emphasis on food safety rules, and ongoing innovation and development initiatives. Key trends predicted for the forecast period encompass accelerated testing methodologies, the increasing utilization of molecular diagnostic approaches, the spread of point-of-care testing into unconventional medical environments, progress in automation and robotics to optimize testing procedures, the discovery of new biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine learning algorithms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

Which Drivers Are Supporting Growth Of The Gastrointestinal Pathogen Testing Market?

An anticipated factor driving the expansion of the gastrointestinal pathogen testing market is the increasing occurrence of foodborne diseases. These diseases are ailments resulting from the ingestion of food or drinks that have been tainted by harmful microorganisms, toxins, or chemical agents. Examples of foodborne diseases encompass listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The increase in foodborne incidents stems from multiple causes, such as shifts in how food is produced, distributed, and consumed, insufficient food safety protocols, and the effects of climate change on agricultural output. Gastrointestinal testing assists in pinpointing the particular pathogens causing foodborne illnesses, thereby enabling healthcare professionals to ascertain the origin of gastrointestinal symptoms, prescribe suitable treatments, monitor outbreaks, and enact preventative steps to curb the transmission of these diseases. For example, data released in February 2024 by the UK Health Security Agency, a government organization in the UK, indicated that England and Wales recorded 167 cases of listeriosis in 2022, an increase from 160 cases reported in 2021. Consequently, the growing frequency of foodborne diseases is a significant catalyst for the expansion of the gastrointestinal pathogen testing market.

What Are The Primary Types Of Segments Analyzed In The Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testingmarket covered in this report is segmented –

1) By Pathogen Type: Bacteria; Viruses; Parasites

2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types

4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users

Subsegments:

1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens

2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens

3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens

What Key Innovation Trends Are Fueling Advancements In The Gastrointestinal Pathogen Testing Market?

Companies operating within the gastrointestinal pathogen testing market are increasingly focused on creating advanced solutions, such as metagenomic diagnostic tests, to improve the precision, speed, and scope of identifying gastrointestinal pathogens. A metagenomic diagnostic test employs sophisticated technology to examine the genetic material of microorganisms found in samples like stool or blood. For example, in April 2024, Microba Life Sciences, an Australian biotechnology firm, launched MetaPanel, a metagenomic diagnostic test designed for highly accurate detection of a broad spectrum of gastrointestinal pathogens. MetaPanel identifies 175 pathogen targets in one test, providing healthcare professionals with a complete tool for diagnosing both common and challenging-to-detect infections. This test utilizes next-generation sequencing (NGS) technology to analyze diverse genetic material within a stool sample, enabling the identification of numerous potential pathogens, including those not typically covered by conventional GI panels.

Who Are The Prominent Global Companies Shaping The Gastrointestinal Pathogen Testing Market?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Region Is Projected To Lead The Gastrointestinal Pathogen Testing Market During The Forecast Period?

North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastrointestinal Pathogen Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2025, By The Business Research Company

Gastrointestinal Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Food Pathogen Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Gastrointestinal Pathogen Testing Market Size from 2025 to 2034?

The market size for gastrointestinal pathogen testing has experienced a consistent upsurge in the last few years. It was valued at $4.05 billion in 2024 and is forecasted to escalate to $4.23 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.4%. The historical growth trend was fueled by factors like the rising occurrences of gastrointestinal infections, increased awareness about foodborne diseases, an uptick in travel-related infections due to globalization, the implementation of regulatory policies concerning food safety, an increase in healthcare expenditure, and an escalating demand for rapid and precise diagnostic procedures.

In the forthcoming years, the gastrointestinal pathogen testing market is predicted to witness consistent expansion, reaching an anticipated market size of $4.92 billion in 2029, at a Compound Annual Growth Rate (CAGR) of 3.9%. This anticipated growth over the forecast period is largely due to the increasing incidence of gastrointestinal infections worldwide, heightened awareness about the benefits of early diagnosis and treatment, the growth of healthcare facilities in developing economies, the surging need for point-of-care testing solutions, increased emphasis on food safety regulations, and sustained R&D endeavors. The upcoming trends for the forecast period comprise swifter testing techniques, rising utilization of molecular diagnostic methods, growth of point-of-care testing in unconventional healthcare environments, advancements in automation and robotics for simplified testing procedures, the development of innovative biomarkers for improved pathogen identification, and incorporation of artificial intelligence and machine learning techniques.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What External and Internal Drivers Are Contributing to the Growth of theGastrointestinal Pathogen Testing Market?

An increase in foodborne disease incidents is anticipated to spur the expansion of the gastrointestinal pathogen testing market. These are illnesses that occur from ingesting food or drinks that have been contaminated with pathogenic microbes, toxins, or chemical compounds. Listeriosis, viral gastroenteritis, taeniasis, and trichinosis are included in the list of foodborne diseases. The swelling number of foodborne cases can be traced back to several factors, such as shifts in food production, distribution and consumption methods, insufficient food safety precautions, and the effect of climate change on food production. Gastrointestinal testing is crucial in pinpointing the particular pathogens that cause foodborne illnesses, enabling healthcare practitioners to identify the source of gastrointestinal symptoms, decide on suitable treatment, monitor outbreaks, and undertake preventive actions to curb the spreading of foodborne diseases. As an illustration, the UK Health Security Agency, a government agency in the UK, stated in February 2024 that there were 167 listeriosis cases in England and Wales in 2022, up from 160 cases the previous year. Therefore, the escalating frequency of foodborne diseases is fuelling the growth of the gastrointestinal pathogen testing market.

What Segment Types Define the Gastrointestinal Pathogen Testing Market Structure?

The gastrointestinal pathogen testingmarket covered in this report is segmented –

1) By Pathogen Type: Bacteria; Viruses; Parasites

2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types

4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users

Subsegments:

1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens

2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens

3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Gastrointestinal Pathogen Testing Market?

North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Gastrointestinal Pathogen Testing Market?

Key industry players in the gastrointestinal pathogen testing market are aiming to develop innovative solutions, such as metagenomic diagnostic tests, to improve the precision, speed, and thoroughness of gastrointestinal pathogen detection. This next-generation technology is used to examine the genetic material of microbes in a given sample, like blood or stool. For example, Microba Life Sciences, a biotech company from Australia, launched MetaPanel in April 2024. This metagenomic diagnostic test was created to detect an extensive range of gastrointestinal pathogens with high precision. With the capability to cover 175 pathogen targets in a single test, MetaPanel provides a comprehensive solution for healthcare professionals, helping them diagnose both standard and challenging-to-detect infections. It employs next-generation sequencing (NGS) technology to scrutinize a wide range of genetic material in a stool sample, allowing it to spot several potential pathogens, some of which are not usually tested for in standard GI (gastrointestinal) panels.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

What Is the Definition of the Gastrointestinal Pathogen Testing Market?

Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gastrointestinal pathogen testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the Gastrointestinal Pathogen Testing Market’s Growth Trajectory From 2025 To 2034?

In recent years, there has been a steady expansion in the market size of gastrointestinal pathogen testing. The projections indicate a growth from $4.05 billion in 2024 to $4.24 billion in 2025, representing a compound annual growth rate (CAGR) of 4.6%. This growth trajectory in previous years can be linked to several factors such as a rise in gastrointestinal infection cases, an increased awareness of foodborne diseases, a surge in travel-related infections due to globalization, regulatory measures aimed at food safety, an escalation in healthcare spending, and an increased demand for fast and accurate diagnostic solutions.

Anticipated to experience consistent growth over the next several years, the market size of gastrointestinal pathogen testing is predicted to reach $5.01 billion by 2029, with a compound annual growth rate (CAGR) of 4.3%. This projected growth during the forecast period can be traced back to a variety of factors. These include the escalating frequency of gastrointestinal infections worldwide, increased consciousness about the significance of early recognition and treatment, the growth of healthcare facilities in developing economies, a surge in demand for point-of-care testing solutions, a heightened emphasis on food safety norms, and ongoing research and innovation efforts. Some key trends expected to characterize the forecast period are swift testing methods, rising acceptance of molecular diagnostic methods, the proliferation of point-of-care testing in non-conventional healthcare settings, progress in automation and robotics for efficient testing procedures, the advent of innovative biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine learning algorithms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

Which Primay Drivers Are Accelerating Growth in the Gastrointestinal Pathogen Testing Market?

The increasing prevalence of foodborne illnesses is anticipated to drive the expansion of the gastrointestinal pathogen testing market. These diseases are typically induced by the ingestion of food or drinks contaminated with pathogenic microbes, toxins, or chemicals, including illnesses like listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The upswing in such diseases can be attributed to several factors, such as changes in the methods of food production, distribution, and consumption, insufficient food safety precautions, and the effect of climate change on food production. These gastrointestinal tests can identify the exact pathogens causing these foodborne diseases, assisting healthcare professionals in determining the reasons for gastrointestinal symptoms, establishing the right treatment, tracking outbreaks, and formulating measures to prevent the further spread of these diseases. For example, in February 2024, the UK Health Security Agency, a government organisation based in the UK, stated that England and Wales had 167 listeriosis cases in 2022 as opposed to 160 cases in 2021. Hence, the escalating rates of foodborne illnesses are fuelling the expansion of the gastrointestinal pathogen testing market.

How Is the Gastrointestinal Pathogen Testing Market Segmented?

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites

2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types

4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:

1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens

2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens

3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Which Regions Are Key Players in the Growth of the Gastrointestinal Pathogen Testing Market?

North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Gastrointestinal Pathogen Testing Market?

Leading firms in the gastrointestinal pathogen testing market are centered around creating advanced solutions such as metagenomic diagnostic tests to improve the precision, speed, and inclusiveness of identifying gastrointestinal pathogens. Metagenomic diagnostics is sophisticated technology that scrutinizes the genome of microorganisms from a sample, such as blood or stool. For example, Microba Life Sciences, a biotech company based in Australia, in April 2024 rolled out MetaPanel which is a metagenomic diagnostic test designed to detect numerous gastrointestinal pathogens with exceptional accuracy. The MetaPanel encompasses 175 pathogen targets in one test, providing medical professionals a complete solution to diagnose both usual and elusive infections. It uses the Next-Generation Sequencing (NGS) technology to examine a vast range of genetic material in a stool sample. This enables the identification of a plethora of potential pathogens, including those not normally checked for in conventional gastrointestinal panels.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

How Is the Gastrointestinal Pathogen Testing Market Defined and What Are Its Core Parameters?

Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Pathogen Testing Market?

An upward trend in foodborne illnesses is anticipated to stimulate the growth of the gastrointestinal pathogen testing market in the future. Foodborne diseases, which typically arise from the consumption of food or drinks contaminated with harmful microbes, toxins, or chemicals, include conditions such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. This surge in foodborne episodes can be attributed to various reasons, such as shifts in how food is produced, distributed, and consumed, insufficient food safety precautions, and the effects of climate change on food production. Gastrointestinal testing is a crucial tool in pinpointing the specific detail of the pathogens responsible for these diseases, aiding healthcare providers to accurately diagnose the source of gastrointestinal symptoms, devise suitable treatments, trace outbreaks, and enforce measures to curb the proliferation of foodborne illnesses. For example, in February 2024, the UK Health Security Agency, a government entity based in the UK, stated that England and Wales witnessed 167 listeriosis cases in 2022, showing an increase from 160 cases in 2021. Therefore, this rising occurrence of foodborne illnesses is fueling the expansion of the gastrointestinal pathogen testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

#How Will the CAGR of the Gastrointestinal Pathogen Testing Market Influence Its Overall Growth by 2034?

In recent years, the market size of gastrointestinal pathogen testing has seen consistent growth. It is expected to rise from $4.05 billion in 2024 to $4.24 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. The growth observed in the past period is due to factors such as an increased incidence of gastrointestinal infections, heightened awareness regarding foodborne diseases, increased instances of infections related to global travel, regulatory measures towards food safety, an upward trend in healthcare spending, and an escalated demand for quick and precise diagnostic solutions.

The market size for testing gastrointestinal pathogens is predicted to undergo constant growth in the foreseeable future, reaching a size of $5.01 billion in 2029 with a compound annual growth rate (CAGR) of 4.3%. This growth during the forecasted timeframe can be traced back to several factors: a hike in the worldwide occurrence of gastrointestinal infections, heightened consciousness regarding the necessity of early diagnosis and treatment, the growth of healthcare framework in emerging markets, increased need for point-of-care testing methods, more strict food safety rules, and ongoing research and development. Key trends for the forecasted period include accelerated testing procedures, wider use of molecular diagnostic methods, the introduction of point-of-care testing into unconventional healthcare environments, progress in automation and robotics to optimize testing procedures, the unveiling of new biomarkers for improved pathogen identification, and the application of artificial intelligence and machine learning algorithms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

What Are the Latest Innovations Influencing theGastrointestinal Pathogen Testing Market?

Leading firms in the gastrointestinal pathogen testing market are concentrating on developing innovative solutions, such as metagenomic diagnostic tests, to augment the precision, rapidity, and breadth of gastrointestinal pathogen detection. Metagenomic diagnostic tests represent a cutting-edge mechanism for inspecting the genetic data of microorganisms in samples like stool or blood. For example, Microba Life Sciences, a biotech firm based in Australia, launched the MetaPanel in April 2024. This metagenomic diagnostic test is engineered to pinpoint a vast array of gastrointestinal pathogens with unprecedented accuracy. The MetaPanel can identify 175 pathogen targets in a single test, providing a holistic solution for health practitioners to diagnose a broad spectrum of both common and elusive infections. Using next-generation sequencing (NGS) technology, it can examine an extensive variety of genetic data in a stool sample. This facilitates the identification of a multitude of possible pathogens, including ones traditionally not tested for in standard gastrointestinal panels.

Who Are the Major Industry Players Accelerating Growth in theGastrointestinal Pathogen Testing Market?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Primary Segments of the Gastrointestinal Pathogen Testing Market Are Driving Growth and Industry Transformations?

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites

2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types

4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:

1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens

2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens

3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Pathogen Testing Market?# Market?

North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2025, By The Business Research Company:

Food Pathogen Safety Testing Equipment And Supplies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Gastrointestinal Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: